Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C V Rizos

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Design|August 20, 2009
Are the pleiotropic effects of telmisartan clinically relevant?C V Rizos, M S Elisaf, E N Liberopoulos
The Open Cardiovascular Medicine Journal|June 11, 2011
Effects of thyroid dysfunction on lipid profileC V Rizos, M S Elisaf, E N Liberopoulos
International Urology and Nephrology|July 27, 2017
Gitelman syndrome: an analysis of the underlying pathophysiologic mechanisms of acid-base and electrolyte abnormalitiesT D Filippatos, C V Rizos, E Tzavella, et al.
Expert Opinion on Drug Safety|February 25, 2009
How safe is the use of thiazolidinediones in clinical practice?C V Rizos, M S Elisaf, D P Mikhailidis, et al.
Expert Opinion on Pharmacotherapy|April 22, 2008
Pleiotropic effects of thiazolidinedionesC V Rizos, E N Liberopoulos, D P Mikhailidis, et al.
Hippokratia|October 1, 2016
Proton pump inhibitors and statins: a possible interaction that favors low-density lipoprotein cholesterol reduction?F Barkas, M Elisaf, C V Rizos, et al.
International Journal of Clinical Practice|August 21, 2009
Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucoseM S Kostapanos, H J Milionis, A-D Agouridis, et al.
Lipids|December 4, 2016
L-Carnitine/Simvastatin Reduces Lipoprotein (a) Levels Compared with Simvastatin Monotherapy: A Randomized Double-Blind Placebo-Controlled StudyM Florentin, M S Elisaf, C V Rizos, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Design|August 20, 2009
Are the pleiotropic effects of telmisartan clinically relevant?C V Rizos, M S Elisaf, E N Liberopoulos
The Open Cardiovascular Medicine Journal|June 11, 2011
Effects of thyroid dysfunction on lipid profileC V Rizos, M S Elisaf, E N Liberopoulos
International Urology and Nephrology|July 27, 2017
Gitelman syndrome: an analysis of the underlying pathophysiologic mechanisms of acid-base and electrolyte abnormalitiesT D Filippatos, C V Rizos, E Tzavella, et al.
Expert Opinion on Drug Safety|February 25, 2009
How safe is the use of thiazolidinediones in clinical practice?C V Rizos, M S Elisaf, D P Mikhailidis, et al.
Expert Opinion on Pharmacotherapy|April 22, 2008
Pleiotropic effects of thiazolidinedionesC V Rizos, E N Liberopoulos, D P Mikhailidis, et al.
Hippokratia|October 1, 2016
Proton pump inhibitors and statins: a possible interaction that favors low-density lipoprotein cholesterol reduction?F Barkas, M Elisaf, C V Rizos, et al.
International Journal of Clinical Practice|August 21, 2009
Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucoseM S Kostapanos, H J Milionis, A-D Agouridis, et al.
Lipids|December 4, 2016
L-Carnitine/Simvastatin Reduces Lipoprotein (a) Levels Compared with Simvastatin Monotherapy: A Randomized Double-Blind Placebo-Controlled StudyM Florentin, M S Elisaf, C V Rizos, et al.
Pageof 1